BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9916467)

  • 1. Fluconazole prophylaxis in patients with head and neck tumours undergoing radiation and radiochemotherapy.
    Mücke R; Kaben U; Libera T; Knauerhase H; Ziegler PG; Hamann D; Strietzel M
    Mycoses; 1998 Nov; 41(9-10):421-3. PubMed ID: 9916467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of fluconazole as antimycotic prophylaxis in radiotherapy of patients with head and neck tumors].
    Mücke R; Kaben U; Libera T; Knauerhase H; Ziegler PG; Hamann D; Strietzel M
    Mycoses; 1997; 40 Suppl 1():53-5. PubMed ID: 9417514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck cancers.
    Koc M; Aktas E
    Jpn J Clin Oncol; 2003 Feb; 33(2):57-60. PubMed ID: 12629054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy.
    Nicolatou-Galitis O; Velegraki A; Sotiropoulou-Lontou A; Dardoufas K; Kouloulias V; Kyprianou K; Kolitsi G; Skarleas C; Pissakas G; Papanicolaou VS; Kouvaris J
    Support Care Cancer; 2006 Jan; 14(1):44-51. PubMed ID: 15947956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
    Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
    Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida dubliniensis in radiation-induced oropharyngeal candidiasis.
    Redding SW; Bailey CW; Lopez-Ribot JL; Kirkpatrick WR; Fothergill AW; Rinaldi MG; Patterson TF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jun; 91(6):659-62. PubMed ID: 11402278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours.
    Finlay PM; Richardson MD; Robertson AG
    Br J Oral Maxillofac Surg; 1996 Feb; 34(1):23-5. PubMed ID: 8645677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial.
    Corvò R; Amichetti M; Ascarelli A; Arcangeli G; Buffoli A; Cellini N; Cionini L; De Renzis C; Emiliani E; Franchini P; Gabriele P; Gobitti C; Grillo Ruggieri F; Bertoni F; Magrini SM; Marmiroli L; Orsatti M; Panizza GM; Tordiglione M; Ziccarelli L; Gava A; Zorat PL; Ghelfi R; Serra GF; Vitale V
    Eur J Cancer Care (Engl); 2008 May; 17(3):270-7. PubMed ID: 18419630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer.
    Redding SW; Dahiya MC; Kirkpatrick WR; Coco BJ; Patterson TF; Fothergill AW; Rinaldi MG; Thomas CR
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jan; 97(1):47-52. PubMed ID: 14716255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
    Metzger S; Hofmann H
    Mycoses; 1997; 40 Suppl 1():56-63. PubMed ID: 9417515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
    Burn AK; Fothergill AW; Kirkpatrick WR; Coco BJ; Patterson TF; McCarthy DI; Rinaldi MG; Redding SW
    J Clin Microbiol; 2004 Dec; 42(12):5846-8. PubMed ID: 15583322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer.
    Redding SW; Kirkpatrick WR; Coco BJ; Sadkowski L; Fothergill AW; Rinaldi MG; Eng TY; Patterson TF
    J Clin Microbiol; 2002 May; 40(5):1879-81. PubMed ID: 11980984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
    Bulacio L; Paz M; Ramadán S; Ramos L; Pairoba C; Sortino M; Escovich L; López C
    J Mycol Med; 2012 Dec; 22(4):348-53. PubMed ID: 23518170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of oropharyngeal mycosis in head and neck cancer occurring during (chemo) radiotherapy: an Italian radio-oncologist survey.
    Belgioia L; Bacigalupo A; Alterio D; Russi E; Corvò R
    Tumori; 2015; 101(3):312-7. PubMed ID: 25908051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study.
    Zilberberg M; Yu HT; Chaudhari P; Emons MF; Khandelwal N; Shorr AF
    Crit Care; 2014 Oct; 18(5):590. PubMed ID: 25358521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash.
    Nicolatou-Galitis O; Dardoufas K; Markoulatos P; Sotiropoulou-Lontou A; Kyprianou K; Kolitsi G; Pissakas G; Skarleas C; Kouloulias V; Papanicolaou V; Legakis NJ; Velegraki A
    J Oral Pathol Med; 2001 Sep; 30(8):471-80. PubMed ID: 11545238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and prevalence of oropharyngeal candidiasis in Spanish patients with head and neck tumors undergoing radiotherapy treatment alone or in combination with chemotherapy.
    Mañas A; Cerezo L; de la Torre A; García M; Alburquerque H; Ludeña B; Ruiz A; Pérez A; Escribano A; Manso A; Glaria LA;
    Clin Transl Oncol; 2012 Oct; 14(10):740-6. PubMed ID: 22960994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
    Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R
    Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.